Expertise in
17
conditions

Johannes J. Levin

Feodor Lynen Str. 17, 
Munich, BY, DE 
Expertise in
17
conditions
Feodor Lynen Str. 17, 
Munich, BY, DE 

Overview

Johannes Levin practices practicing medicine in Munich, Germany.

Mr. Levin is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Dementia, Alzheimer's Disease, Progressive Supranuclear Palsy Atypical, Progressive Supranuclear Palsy, and Thrombectomy.

He is actively involved in clinical research, co-authoring 441 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Feodor Lynen Str. 17, Munich, BY 81377, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: July 27, 2026
Intervention Type: Drug
Study Drugs: E2814, Lecanemab
Study Phase: Phase 2/Phase 3
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: July 27, 2026
Intervention Type: Drug
Study Drugs: Gantenerumab, Solanezumab
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

440 Total Publications

Longitudinal Dynamics of the Blood Proteome Within the Alzheimer Spectrum in Down Syndrome.
Longitudinal Dynamics of the Blood Proteome Within the Alzheimer Spectrum in Down Syndrome.
Journal: Neurology
Published: September 01, 2026

Frequently Asked Questions about Johannes J. Levin

Is Johannes J. Levin a top-rated expert for Dementia?

MediFind is an objective health platform that identifies experts based on real-world data. Johannes J. Levin is classified as an Distinguished expert for Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Johannes J. Levin participate in research or clinical trials?

Yes. Johannes J. Levin has published 440 articles and abstracts on conditions like Dementia. You can view a list of Johannes J. Levin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Levin's expertise for a condition
ConditionClose
    View All 12 Distinguished Conditions
    View All 42 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile